|Dr. Johannes Zimmermann|
works as an Associate for Catenion GmbH and joined the company in 2015. With Catenion he facilitated the digital transformation for several major pharmaceutical companies and developed financial models to predict the impact of novel technologies on the pharmaceutical value chain. Johannes Zimmermann studied biochemistry in Hannover, Los Angeles and Göttingen and did his PhD in neurobiology at the Charité Berlin.
|Dr. Markus Thunecke|
is a founding Senior Partner of Catenion GmbH and has more than 20 years of experience as a biopharma strategy consultant. He supports (...)